etectRx's ingestible adherence tracker system cleared by FDA
Publication Title
MobiHealthNewsPublication/Creation Date
December 9 2019Creators/Contributors
Dave Muoio (creator)EtectRx (contributor)
Brigham And Women's Hospital (contributor)
Proteus Digital Health (contributor)
Food And Drug Administration (FDA) (contributor)
Media Type
Magazine ArticlePersuasive Intent
InformationDescription
"Gainesville, Florida-based etectRx has received FDA 510(k) clearance for its ID-Cap System, a prescription ingestible system that sends adherence event logs to an external medical device.Similar to the system pioneered by etectRx’s high-profile competitor, Proteus Digital Health, the ID-Cap’s core is a standard capsule containing a sensor that transmits a message once it comes into contact with stomach fluid.
However, the ID-Cap System’s receiving device does not need to be adhered to the user’s skin — as is the case for Proteus’ system — but can instead be worn on a lanyard. This receiver then forwards the adherence event data to secure provider web portal, by way of an intermediary patient smartphone app."
HCI Platform
IngestibleDiscursive Type
Responses To InventionsTechnology Keywords
Ingestible Sensors, Ingestible Capsules, Ingestible Adherence Tracking System, Digital Pills, Medical Device, Smartphone Applications, Web PortalKeywords
Medical, Medication, Pharmaceuticals, Health, Compliance, Patients, Ethics, Regulation, PrivacySource
https://www.mobihealthnews.com/news/north-america/etectrxs-ingestible-adherence-tracker-system-cleared-fdaRelated Objects
Proteus Digital Health - Your Health, Powered By YouThe ID-Cap™ System - Revolutionizing Remote Patient Monitoring
Abilify MyCite® Overview
Related Items
MobiHealthNewsDave Muoio
EtectRx
Brigham And Women's Hospital
Proteus Digital Health
Food And Drug Administration (FDA)